Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients ≥65 years of age (The Italian longitudinal study on aging)

被引:33
|
作者
Solfrizzi, V
Panza, F
Colacicco, AM
Capurso, C
D'Introno, A
Torres, F
Baldassarre, G
Capurso, A
机构
[1] Univ Bari Policlin, Ctr Lipoprotein Metab, Dept Geriatr, I-70124 Bari, Italy
[2] Miulli Reg Hosp, Div Geriatr, Bari, Italy
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 89卷 / 07期
关键词
D O I
10.1016/S0002-9149(02)02192-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High levels of serum lipoprotein(a) [Lp(a)] have been associated with increased risk of coronary artery disease (CAD), but this association apparently is not confirmed in elderly people. We evaluated the interactions of Lp(a) with lipid and nonlipid CAD risk factors in a sample of subjects enrolled in the prevalence survey (1992 to 1993) of the Italian Longitudinal Study on Aging (ILSA). The entire population consisted of 5,632 elderly people, aged 65 to 84 years, randomly selected in 8 Italian municipalities. The present cross-sectional study included 400 free-living elderly subjects (74 +/- 6 years) from the randomized cohort of Casamossima (Bari, Southern Italy) (n = 704). The results showed that in the elderly population, high serum Lp(a) is a CAD risk factor dependent on type 2 diabetes mellitus and elevoted low-density lipoprotein (LDL) cholesterol levels. In particular, the combined effect of high Lp(a) (greater than or equal to20 mg/ dl) and high LDL cholesterol (greater than or equal to3.63 mmol/L [greater than or equal to140 mg/dl]), increases coronary risk by 2.75 (95% confidence interval 7.70 to 0.99); finally, the effect of Lp(a) greater than or equal to20 mg/dl and LDL cholesterol greater than or equal to3.63 mmol/L (greater than or equal to140 mg/dl), combined with type 2 diabetes mellitus, increases risk of CAD by 6.65 (95% confidence interval 35.40 to 1.25). In the elderly, elevated Lp(a) levels appear not to be an independent predictor of CAD, but this lipoprotein is a risk factor only in subjects with type 2 diabetes mellitus and elevated LDL cholesterol. (C) 2002 by Excerpta Medica, Inc.
引用
收藏
页码:825 / 829
页数:5
相关论文
共 50 条
  • [21] Genetic Predisposition to Low-Density Lipoprotein Cholesterol and Incident Type 2 Diabetes
    Ravi, Akshaya
    Koyama, Satoshi
    Cho, So Mi Jemma
    Haidermota, Sara
    Hornsby, Whitney
    Ellinor, Patrick T.
    Natarajan, Pradeep
    JAMA CARDIOLOGY, 2025,
  • [22] Association of Very Low-density Lipoprotein Cholesterol With Coronary Artery Calcification in Type-2 Diabetes
    Prenner, Stuart B.
    Mulvey, Claire K.
    Qasim, Atif N.
    Bhatt, Anish
    Terembula, Karen
    Iqbal, Nayyar
    Reilly, Muredach P.
    CIRCULATION, 2013, 128 (22)
  • [23] Effect of Helicobacter pylori Eradication on Low-Density Lipoprotein Cholesterol in Patients With Type 2 Diabetes
    Alsalman, Omar
    Shady, Ahmed
    Yerragorla, Priyanka
    Al-juboori, Mohammed
    Boktor, Hala
    Bustos, Aulio
    Alchalabi, Marwah
    Harley, Jennifer
    Bergasa, Nora
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S703 - S704
  • [24] Adherence to recommendations for low-density lipoprotein lowering in patients with type 2 diabetes mellitus.
    Ahmed, N
    Evans, SL
    Brousil, JA
    PHARMACOTHERAPY, 2004, 24 (10): : 1426 - 1427
  • [25] Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease
    Hu, Gang
    Cui, Yadong
    Jousilahti, Pekka
    Sundvall, Jouko
    Girman, Cynthia J.
    Antikainen, Riitta
    Laatikainen, Tiina
    Tuomilehto, Jaakko
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (01) : 89 - 97
  • [26] Effect of Improving Glycemic Control in Patients With Type 2 Diabetes Mellitus on Low-Density Lipoprotein Size, Electronegative Low-Density Lipoprotein and Lipoprotein-Associated Phospholipase A2 Distribution
    Sanchez-Quesada, Jose L.
    Vinagre, Irene
    de Juan-Franco, Elena
    Sanchez-Hernandez, Juan
    Blanco-Vaca, Francisco
    Ordonez-Llanos, Jordi
    Perez, Antonio
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (01): : 67 - 71
  • [27] Usefulness of low-density lipoprotein to high-density lipoprotein cholesterol ratio as a predictor of clinical outcomes after percutaneous coronary intervention in patients with diabetes mellitus
    Nomura, A.
    Yamaji, K.
    Watanabe, H.
    Kuramitsu, S.
    Soga, Y.
    Iwabuchi, M.
    Yokoi, H.
    Nobuyoshi, M.
    EUROPEAN HEART JOURNAL, 2012, 33 : 449 - 450
  • [28] Effects of Simvastatin and Ezetimibe in Lowering Low-Density Lipoprotein Cholesterol in Subjects with Type 1 and Type 2 Diabetes Mellitus
    Ciriacks, Kevin
    Coly, Gerard
    Krishnaswami, Shanthi
    Patel, Shailendra B.
    Kidambi, Srividya
    METABOLIC SYNDROME AND RELATED DISORDERS, 2015, 13 (02) : 84 - 90
  • [29] Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
    Moon, Min Kyong
    Noh, Junghyun
    Rhee, Eun-Jung
    Park, Sang Hyun
    Kim, Hyeon Chang
    Kim, Byung Jin
    Kim, Hae Jin
    Choi, Seonghoon
    Na, Jin Oh
    Hyun, Young Youl
    Kim, Bum Joon
    Han, Kyung-Do
    Jeong, In-Kyung
    DIABETES & METABOLISM JOURNAL, 2023, 47 (01) : 45 - 58
  • [30] Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol
    Alsheikh-Ali, Alawi A.
    Lin, Jen-Liang
    Abourjaily, Paul
    Ahearn, Dineli
    Kuvin, Jeffrey T.
    Karas, Richard H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (10): : 1499 - 1501